📅Offer Date: 04 Aug 2023 – 08 Aug 2023
Data sourced from BSE & NSE · Last updated
Concord Biotech Limited IPO was subscribed 24.86x in total when bidding closed on 08 Aug 2023, with 67.67x in the QIB category, 16.99x in NII, 3.77x in retail. The issue ran from 04 Aug 2023 to 08 Aug 2023 at a price band of ₹705.00–₹741.00 per share.
Times subscribed by category against the 1× line.
Based on retail subscription (3.77x). Final allotment decided by registrar's computerised lottery.
| Category | Offer | Applied | Times |
|---|---|---|---|
| QIBs | 41,83,130 | 28,30,72,407 | 67.67x |
| NIIs | 31,37,348 | 5,33,03,543 | 16.99x |
| SNIIs (<10L) | 10,45,783 | 1,29,25,878 | 12.36x |
| BNIIs (>10L) | 20,91,565 | 4,03,67,205 | 19.30x |
| Retail | 73,20,479 | 2,75,98,206 | 3.77x |
| Employee | 10,000 | 2,43,900 | 24.39x |
| Total | 1,46,50,957 | 36,42,22,791 | 24.86x |
| Category | Offered | Demand | Times |
|---|---|---|---|
| QIBs | 309.97 | 20975.67 | 67.67x |
| NIIs | 232.48 | 3949.79 | 16.99x |
| Retail | 542.45 | 2045.03 | 3.77x |
| Employee | 0.74 | 18.07 | 24.39x |
| Total | 1085.64 | 26988.56 | 24.86x |
Values derived from share count × issue price (₹741.00)
Because Concord Biotech Limited closed oversubscribed, allotment follows the applicable category and exchange rules. A high subscription figure reflects strong demand but does not guarantee a premium listing, and a low figure does not guarantee a discount. This page is for information only and is not investment advice.
BSE, NSE listed · Bidding data sourced from BSE & NSE under SEBI ICDR regulations.